Vanguard Capital Management
CDLX icon

Vanguard Capital Management’s Cardlytics CDLX Stock Holding History

Vanguard Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$643K Hold
218,612
– – ﹤0.01% 3646
2026
Q2 		$982K Buy
218,612
+12,275
+6% +$91.8K ﹤0.01% 3596
2026
Q1 		$2.17M Buy
+206,337
New +$2.01M ﹤0.01% 3338

Other funds holding CDLX

KPS Global Asset Management (UK)
KPS Global Asset Management (UK) London, United Kingdom $625M AUM 17% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
RBF Capital
RBF Capital San Francisco, California $2.3B AUM 22.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Quinn Opportunity Partners
Quinn Opportunity Partners Charlottesville, Virginia $1.85B AUM 1.27% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Kingsbury Capital Investment Advisors
Kingsbury Capital Investment Advisors Wilmette, Illinois $106M AUM

Vanguard Capital Management's CDLX Position: Q3 2026 in Review

Vanguard Capital Management held its Cardlytics (CDLX) position steady in Q3 2026 at 218,612 shares worth $643K. The position accounts for ﹤0.01% of the portfolio, ranked #3646.

Vanguard Capital Management first reported a position in CDLX in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.17M in Q1 2026. 31 funds tracked by Wall St. Rank hold CDLX as of Q3 2026.

  • Vanguard Capital Management held 218,612 shares of Cardlytics worth $643K as of Q3 2026.
  • Vanguard Capital Management left its Cardlytics share count unchanged in Q3 2026.
  • Cardlytics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3646 holding.
  • Vanguard Capital Management first reported a position in Cardlytics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Cardlytics position peaked at $2.17M in Q1 2026.
  • 31 funds tracked by Wall St. Rank held Cardlytics as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.